Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 63 articles: HTML format

Single Articles

January 2008
1. MORI R , Wang Q, Quek ML, Tarabolous C, et al
   Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
2. LICASTRO F , Bertaccini A, Porcellini E, Chiappelli M, et al
   Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
3. WEI J , Xu G, Wu M, Zhang Y, et al
   Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
4. HSIEH TC , Wang Z, Deng H, Wu JM, et al
   Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   November 2007
5. NASELLI A , Andreatta R, Introini C, Fontana V, et al
   Omission of lymphadenectomy in low risk prostate cancer.
   Anticancer Res. 2007;27.
   PubMed     Related articles    Abstract available
   
   
   
6. ERGEN HA , Gormus U, Narter F, Zeybek U, et al
   Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
   Anticancer Res. 2007;27.
   PubMed     Related articles    Abstract available
   
   
   
7. KIM MH , Chung J
   Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line.
   Anticancer Res. 2007;27.
   PubMed     Related articles    Abstract available
   
   
   
8. IGUCHI K , Tatsuda Y, Usui S, Hirano K, et al
   Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells.
   Anticancer Res. 2007;27.
   PubMed     Related articles    Abstract available
   
   
   
9. SUN Y , Eichelbaum EJ, Wang H, Vesely DL, et al
   Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
   Anticancer Res. 2007;27.
   PubMed     Related articles    Abstract available
   
   
   
10. ECKE TH , Schlechte HH, Hubsch A, Lenk SV, et al
    TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
11. SCHLOTT T , Eiffert H, Schmidt-Schultz T, Gebhardt M, et al
    Detection and analysis of cancer genes amplified from bone material of a Scythian royal burial in Arzhan near Tuva, Siberia.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
12. TAYMOORIAN K , Thomas A, Slowinski T, Khiabanchian M, et al
    Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    September 2007
13. REVELOS K , Petraki C, Scorilas A, Stefanakis S, et al
    Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
14. ORECCHIA R , Jereczek-Fossa BA, Ciocca M, Vavassori A, et al
    Intraoperative radiotherapy for locally advanced prostate cancer: treatment technique and ultrasound-based analysis of dose distribution.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
15. HORVATH Z , Marihart-Fazekas S, Saiko P, Grusch M, et al
    Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
16. PALWAI NR , Zang XP, Harrison RG, Pento JT, et al
    Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
17. KIM J , Park H, Im JY, Choi WS, et al
    Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
18. SINHA AA , Morgan JL, Buus RJ, Ewing SL, et al
    Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
19. DEEB D , Gao X, Dulchavsky SA, Gautam SC, et al
    CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
20. CHANG CH , Hsu WC, Wang CY, Jan ML, et al
    Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
21. GRIDLEY DS , Makinde AY, Luo X, Rizvi A, et al
    Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    July 2007
22. BERGNER CC , Krause FS, Zugor V, Rith T, et al
    Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
23. FISCHER K , Hamza A, Wicht A, Loertzer H, et al
    Shift of the f/t-PSA quotient in relation to renal insufficiency: consequences for the early detection of prostate carcinoma in patients with terminal renal failure.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
24. BRUNS F , Franzki C, Wegener G, Karstens JH, et al
    Definitive conformal radiotherapy for localized high-risk prostate cancer: a long-term follow-up study with PSA course.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
25. STEPHAN C , Meyer HA, Paul EM, Kristiansen G, et al
    Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
26. FEYERABEND S , Feil G, Krug J, Kassen A, et al
    Cytotoxic effects of treosulfan on prostate cancer cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
27. NARAYANAN NK , Nargi D, Attur M, Abramson SB, et al
    Anticancer effects of licofelone (ML-3000) in prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
28. STAHLBERG K , Kairemo K, Karonen SL, Taari K, et al
    Distribution of radioiodinated estramustine binding protein antibody in mice with DU-145 prostate cancer xenograft.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
29. BAU DT , Wu HC, Chiu CF, Lin CC, et al
    Association of XPD polymorphisms with prostate cancer in Taiwanese patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
30. BUSSING A , Stumpf C, Troger W, Schietzel M, et al
    Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
31. CUSTOVIC Z , Kraus O, Tomaskovic I, Tarle M, et al
    Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
32. KIM S , Hwang BY, Su BN, Chai H, et al
    Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
33. FRIEDRICH RE , Blake FA
    Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    May 2007
34. COPELAND RL JR , Das JR, Bakare O, Enwerem NM, et al
    Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
35. INCORVAIA L , Badalamenti G, Rini G, Arcara C, et al
    MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
36. JACKSON KM , Frazier MC, Harris WB
    Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
37. SINHA AA , Morgan JL, Wood N, Betre K, et al
    Heterogeneity of cathepsin B and stefin A expression in Gleason pattern 3+3 (score 6) prostate cancer needle biopsies.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
38. SUN Y , Eichelbaum EJ, Wang H, Vesely DL, et al
    Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
39. MASTERS JR
    Clinical applications of expression profiling and proteomics in prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    March 2007
40. ERGEN HA , Narter F, Timirci O, Isbir T, et al
    Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study.
    Anticancer Res. 2007;27:1227-30.
    PubMed     Related articles    Abstract available
    
    
    
41. PREZIOSO D , Galasso R, Di Martino M, Iapicca G, et al
    Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
    Anticancer Res. 2007;27:1095-104.
    PubMed     Related articles    Abstract available
    
    
    
42. YIGIT B , Bozkurt N, Narter F, Yilmaz H, et al
    Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis.
    Anticancer Res. 2007;27:933-6.
    PubMed     Related articles    Abstract available
    
    
    
43. RAMACHANDRAN K , Navarro L, Gordian E, Das PM, et al
    Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells.
    Anticancer Res. 2007;27:921-5.
    PubMed     Related articles    Abstract available
    
    
    
44. DESCOTES JL , Legeais D, Gauchez AS, Long JA, et al
    PSA measurement following prostatectomy: an unexpected error.
    Anticancer Res. 2007;27:1149-50.
    PubMed     Related articles    Abstract available
    
    
    
45. MATSUNAGA S , Iguchi K, Usui S, Hirano K, et al
    Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells.
    Anticancer Res. 2007;27:927-32.
    PubMed     Related articles    Abstract available
    
    
    
46. HOSTANSKA K , Suter A, Melzer J, Saller R, et al
    Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines.
    Anticancer Res. 2007;27:873-81.
    PubMed     Related articles    Abstract available
    
    
    January 2007
47. GOEB K , Engehausen DG, Krause FS, Hollenbach HP, et al
    MRI spectroscopy in screening of prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
48. FILELLA X , Alcover J, Molina R, Luque P, et al
    Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
49. TAKAGI A , Watanabe M, Ishii Y, Morita J, et al
    Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
50. WARE JH , Zhou Z, Guan J, Kennedy AR, et al
    Establishment of human cancer cell clones with different characteristics: a model for screening chemopreventive agents.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
51. BERTACCINI A , Fandella A, Prayer-Galetti T, Scattoni V, et al
    Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    November 2006
52. WARE JH , Zhou Z, Kopelovich L, Kennedy AR, et al
    Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell line.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
53. SUN Y , Eichelbaum EJ, Wang H, Vesely DL, et al
    Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
54. SALMINEN EK , Kallioinen MJ, Ala-Houhala MA, Vihinen PP, et al
    Survival markers related to bone metastases in prostate cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
55. AALTOMAA S , Karja V, Lipponen P, Isotalo T, et al
    Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    September 2006
56. HUANG YW , Wang LS, Chang HL, Ye W, et al
    Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
57. CARDILLO MR , Ippoliti F
    IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
58. SUN Y , Eichelbaum EJ, Wang H, Vesely DL, et al
    Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
59. STEELE VE , Arnold JT, Lei H, Izmirlian G, et al
    Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
60. MITSIADES CS , Bogdanos J, Karamanolakis D, Milathianakis C, et al
    Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
61. TEJEDA M , Gaal D, Hullan L, Hegymegi-Barakonyi B, et al
    Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
62. SHIBAHARA T , Onishi T, Franco OE, Arima K, et al
    A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
63. MI Q , Kim S, Hwang BY, Su BN, et al
    Silvestrol regulates G2/M checkpoint genes independent of p53 activity.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: